Related Experiment Video

Updated: Sep 13, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.5K

Advances in research on SATB2 and its role in tumor development

Ge Cheng1,2, Chi Tian1,2, Waner Wang1,2

  • 1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Henan University, Kaifeng, 475004, China.

Cell & Bioscience
|July 29, 2025
PubMed

Insights

SATB2, a DNA-binding protein, is crucial in gene regulation and cell functions. Its dysregulation is linked to cancers and SATB2-associated syndrome, highlighting its potential as a diagnostic and therapeutic target.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • SATB2 is an AT-rich DNA-binding protein with restricted expression in the brain, digestive tract, bone, and immune system.
  • Dysregulation of SATB2 is associated with cancers, isolated cleft palate, and SATB2-associated syndrome (SAS).

Purpose of the Study:

  • To comprehensively review the structure, biological functions, and role of SATB2 in tumor development.
  • To explore SATB2's potential as a diagnostic marker and therapeutic target in oncology and bone disorders.

Main Methods:

  • Literature review of existing studies on SATB2.
  • Analysis of SATB2's influence on gene regulation via epigenetic modulation.
  • Examination of SATB2's role in cell differentiation and immune responses.

Main Results:

  • SATB2 plays a role in epigenetic modulation, affecting gene expression, cell differentiation, and immune responses.
  • Emerging evidence implicates SATB2 in tumorigenesis, cancer progression, and metastasis.
  • SATB2 demonstrates potential as a biomarker and therapeutic target for cancers and bone disorders.

Conclusions:

  • SATB2's multifaceted roles in gene regulation and cellular processes underscore its significance in health and disease.
  • Further understanding of SATB2's mechanisms is essential for developing novel therapeutic strategies in oncology and regenerative medicine.
Keywords:
Epigenetic modulationGene regulationSATB2Tumor development

More Related Videos

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

2.7K
Three-Dimensional 3D Tumor Spheroid Invasion Assay12:19

Three-Dimensional 3D Tumor Spheroid Invasion Assay

Published on: May 1, 2015

58.0K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K